Bill Nielson

Bill Nielson, retired Vice President of Public Affairs for Johnson and Johnson came this week to speak to our class about some general insight for what it was like working for a huge company like JNJ.
He said that his favorite part about working in the communications world is "the daily challenges he had to face, and the constant change. No two days were ever the same".
He explained people in the Public Relations field as "generalists"--we can handle a lot of things at once and are especially good listeners. He also emphasized that to make it in the Public Relations world, you MUST be a good writer.
Nielson had never even heard the word "Public Relations" during his 4 years in college. The first place he learned about it was when he enrolled in the air force straight after college graduation.

In 1988 Nielson went to Johnson and Johnson, and to him it was a dream job. He knew Johnson and Johnson was a company with a great reputation and ever since he took the offer he never looked back. What he liked most about his stay at Johnson & Johnsonwas that they were and still are a valued based company, surrounded by terrific people.

Coroprate Setting

• Alot of disiplines you have to deal with like the rules and regulations of general laws, Human Resources and the finance and accounting departments. Each of these sectors must work together perfectly and be in sync inorder to run a smooth operation like Johnson and Johnson does.
• It needs to be "seemless" as Nielson puts it, and we PR experts exsits for this reason. We play the role of filling in what needs to be done between those lines, or in the "grey space".

Always Remember

*Employees are your 1st and most important audience in a corporation like Johnson and Johnson, they comes the media. Johnson and Johnson always wanted support from the internal audience, their employees before they reached out to their extrenal ones.

Johnson & Johnson Attempts Prime Time TV

The Johnson & Johnson Spotlight Presentation(sm) series is the latest effort by Johnson & Johnson to bring original films and programming that are family friendly to prime time television. As the founder of the Family Friendly Programming Forum, which now includes more than 40 national advertisers dedicated to expanding family viewing options, Johnson & Johnson has long supported the development of quality television programs that the entire family can watch together. Through collaboration with Turner Network Television (TNT), the Johnson & Johnson Spotlight Presentation(sm) series produces original movies that focus on the importance of family values and relationships.

Johnson & Johnson has long supported the development of quality television programs that the entire family can watch together. The Johnson & Johnson Spotlight Presentation series is the latest effort by Johnson & Johnson to bring original films and programming that are family friendly to prime time television.

Since early 2002, Johnson & Johnson has collaborated with Turner Network Television (TNT) to develop original films that celebrate the human spirit and the strength of family bonds. Johnson & Johnson Spotlight Presentations represent an important effort by Johnson & Johnson, the founding member of the Family Friendly Programming Forum of advertisers, to expand family-friendly programming on prime time television. The first film in the Johnson & Johnson Spotlight Presentation series, the critically acclaimed and Emmy award-winning Door to Door.

The Engagement Ring, starring Patricia Heaton, is a romantic holiday story set in the Napa Valley wine country. Lost in the mail for many years, an engagement ring and a marriage proposal are finally delivered. Through the ring, originally intended for her mother, Heaton's character discovers the meaning of love, friendship and living life to its fullest.
Door to Door Door to Door, the first film in the Johnson & Johnson Spotlight Presentation series, stars Oscar-nominated actor William H. Macy and is an inspirational drama based on the true story of Bill Porter, a door-to-door salesman born with cerebral palsy. Door to Door recounts the changing times of our country through the life of one amazing man and the neighborhoods he walked. The critically acclaimed and Emmy® award-winning Door to Door received TV Guide’s highest rating and topped all broadcast networks head-to-head in the 53 metered markets in primetime.

Miss Lettie and Me Miss Lettie and Me features an award-winning cast that includes Mary Tyler Moore, Burt Reynolds, Charlie Robinson and Irma P. Hall, along with Holliston Coleman as a spirited child who helps her Aunt Lettie learn to open her heart and love again. In turn, Lettie teaches her niece that life’s richest treasures are where you least expect to find them. Together they both learn that they need each other more than they ever thought possible. In 2004, Miss Lettie and Me was one of five motion pictures honored with the CAMIE Award, presented by CAMIE awards, Inc. (Character And Morality In Entertainment), to recognize uplifting and inspiring programs.

Wilder Days Wilder Days is about the challenges and rewards of maintaining family connections and keeping the magic of childhood alive. Wilder Days tells the story of a workaholic father (Tim Daly) who is brought closer to his son (Josh Hutcherson), who is enthralled by the fantastic stories his grandfather (Peter Falk) tells him. The joys and heartbreaks of family life unfold in Wilder Days as three generations embark on an odyssey that leads the family members to a new understanding of one another.

The Winning Season, which stars Matthew Modine and Kristin Davis, tells the story of a 12-year old baseball fanatic who finds a mint condition Honus Wagner baseball card, only to discover that it is more than the world's most valuable card - it is also a granter of wishes. Through it, Joe goes back to the 1909 World Series on an amazing journey that will change his, Honus' (Modine) and Mandy's (Davis) lives forever.

The Wool Cap Based upon the original story Gigot written by Jackie Gleason, The Wool Cap stars Emmy® award-winning actor William H. Macy as a mute building superintendent who is tortured by his past but finds new life when he befriends a bright, young girl who is abandoned by her mother.

14 Hours Based on a true story, 14 Hours recalls the harrowing events of June 2001, when Tropical Storm Allison stalled over the Houston metropolitan area, pouring nearly 30 inches of rain on the city within a 14-hour period. The thrilling action takes place at Memorial Hermann Hospital, where the instincts of the hospital's nurses, doctors and staff, coupled with support from community volunteers, helped ensure that over 500 patients were evacuated safely. mother.

Support to Nursing

The Campaign for Nursing's Future

In 2002, Johnson & Johnson launched The Campaign for Nursing's Future, a multi-year, public awareness campaign designed to enhance the image of the nursing profession, recruit new nurses and nurse faculty, and help retain nurses currently in the profession. Campaign elements have included a national television, print and interactive advertising campaign in English and Spanish celebrating nursing professionals and their contributions to health care; recruitment materials also in English and Spanish distributed free of charge; fundraising for student scholarships, faculty fellowships, and grants to nursing schools to expand their program capacity; celebrations at regional nursing events to excite and empower the local nursing community; a website (http://www.jnj.com/exit_warning.jsp?url=http%3A%2F%2Fwww.discovernursing.com) about the benefits of a nursing career featuring searchable links to hundreds of nursing scholarships, and more than 1,000 accredited nursing educational programs; and activities to create and fund retention programs designed to improve the nursing work environment.

The Campaign has received numerous awards from many major health care, nursing trade and professional organizations, including the Ron Brown Award for Corporate Leadership, the only Presidential honor given to companies for their community involvement.

"America's Nurses: They Dare to Care" is the theme of the campaign Johnson & Johnson introduced in 2002 to salute nurses and encourage people to enter the nursing profession, which is facing a severe manpower shortage. Johnson & Johnson's commitment to this campaign represents a top corporate priority and reflects the Company's Credo commitment to nurses, the community and to all of health care. The Web site www.discovernursing.com is where students can find information on becoming a nurse, find a nursing program that's right for them, search the largest database of nursing scholarships on the web, and find links to major nursing organization sites.

Keeping Up with Social Responsibility

Johnson & Johnson Presents Donations To Non-Profit Groups
San Juan, Puerto Rico (April 19, 2007) – The Johnson & Johnson Family of Companies has distributed donations totaling $600,000 to 26 non-profit organizations on the island to support their projects in the areas of health, education and community responsibility.
The donations were presented in a ceremony held at the Caribe Hilton Hotel on April 19 during which the company – for the 18th consecutive year – paid tribute to the work being done by the non-profit groups to help the island’s less fortunate families.
In addition, Johnson & Johnson used the occasion to honor 12 employees, each representing one of the company's operations on the island, for their outstanding service to the community in keeping with Johnson & Johnson's Credo.
Iris Ramos, director of public affairs, noted that the $600,000 donation represents only part of the company's total contributions to the non-profit sector since the various Johnson & Johnson companies also sponsor projects and programs in the communities where they operate. Johnson & Johnson has eight manufacturing plants, as well as three sales and marketing offices and a central business services unit on the island.
Among the special guests attending the ceremony were Popular Democratic Party Sen. Sila Marie González and University of Puerto Rico President Antonio García Padilla. Each delivered a message thanking Johnson & Johnson for its support of the non-profit organizations.
Speaking on behalf of Johnson & Johnson at the ceremony were: Donald Bohn, vice president of Government Affairs; Dr. Rick A. Martínez, director of Corporate Donations and Community Relations for Latin America; Edgardo Fábregas, vice president of the Pharmaceutical Supplies Group for Puerto Rico, Latin America and Asia Pacific; and Margarita Hernández, director of Global New Products Development. All four stressed that helping the community is a key element in Johnson & Johnson's Credo.
Eight non-profit organizations received grants in the community responsibility category: the Alliance for a Puerto Rico without Drugs, the American Heart Association, the Handicapped Persons Association, the Rvda. Inés J. Figueroa Community Foundation, the Center for Family Education, Crearte, the Salvation Army and the Office for the Promotion of Human Health.
There were nine recipients in the children's health category: the Respiro Program, the DAR Foundation, the Pro-Pediatric Oncology Department Foundation, the Down Syndrome Foundation, the San Jorge Foundation, the San Germán Children’s Home, the Regazo de Paz Children's Home, the San Cristobal Children's Home and the group "Corazones Unidos."
The public health category had five recipients: "Estancia Corazón", the Alzheimer Federation, the group "Perla de Gran Precio", the Movement to Achieve an Independent Life and the American Cancer Society.
Four non-profits received grants in the health education category: the "Casa del Peregrino" in Aguadilla, the Community Research Initiative, the School-to-Career Center (BTE) and the University of Puerto Rico's Nurses Scholarship Program.
# # #

Olympics

Olympics Sponsorship
On July 26, 2005, Johnson & Johnson and its subsidiaries made a multi-national commitment to the Olympic Movement, becoming the Official Health Care Products Sponsor of the Torino 2006 Olympic Winter Games, an Official Partner of the Beijing 2008 Olympic and Paralympic Games and an Official Health Care Partner in more than 20 additional countries around the world. On February 23, 2006, Johnson & Johnson announced that the Company joined The Olympic Partners (TOP) Programme of the International Olympic Committee (IOC) as the Official Health Care Products Sponsor.
The partnership encompasses the Company’s major business lines: consumer products, pharmaceuticals, and medical devices and diagnostics.
Johnson & Johnson and the XX Olympic Winter Games As Official Health Care Products Sponsor of the XX Olympic Winter Games, the Company and its operating companies conducted a series of activities to capture the spirit of the Games for both local residents and spectators visiting from around the globe.
Please click below to read more about our activities in Torino:
Johnson & Johnson and the XX Olympic Winter Games

Sport for Good Health

Right to Play Partnership

Investor Relations

The Johnson & Johnson annual report is much more geared toward an economical piece then a slick marketing piece. The first 20 pages are mainly the only ones with vidid pictures of Johnson & Johnson products, mostly newly aquired ones giving an explaination about them and their family companies. However, 20 mpages out of 77, with scattered images makes me believe that the Johnson & Johnson annual report focues to be more of an economical piece.. The rest of the annual report is all financial explanations, numerous graphs and data analysis.

• The company easily allows you to view their SEC 10-K filing right on the investor relations link from the website. The document is dated on February 16th, 2007 and allows all shareholders to access the information needed to see how JNJ performed for this fiscal year.
  10-K and 10-Q
  The 10-K annual report provides a comprehensive overview of Johnson & Johnson's business as of the end of each fiscal year. The 10-Q is filed quarterly following each of the first three fiscal quarters and includes unaudited financial statements and a current view of the Company's financial position as of the end of the quarter.A link to the document is below: http://www.shareholder.com/Common/Edgar/200406/950123-07-2542/07-00.pdf
• From reviewing Johnson & Johnsons annual report I think their goal is to continue to reinstate the companies values and show earnings for the year. With 90% of the document being very technical information, and extremly long and wordy, as most annual reports are I would have to say that the goal is not to just tell its story. It is to get into the nitty gritty numbers and anaylsis of the products they offer to ther customers. However, in true Johnson and Johnson style the back cover of their annual report has their credo streatching throughout the whole page, ones again always reminding the public who and what Johnson and Johnson stands for. As with all annual reports, you expect them to get into great detail about facts and figures, earnings, financial statements, etc. It is a cut and dry as it can be, and only a very small amount of people are looking for this in-depth analysis so this is why they present the extensive information the way they have in their annual report.
• The compamnys letter to the shareholders from CEO, William C. Weldon is the first 4 pages of the annual report. It shows to express honesty about how the company has made record financial progress and growth to be expected in the near future. The key messages that are coming through are explaing what products worked very well and were aids in the success of JNJs financial earnings this year, and which one weren't like in the hopes of a product in the cardiovascular field with the aquisition of Guardiant Corporation. A year ago JNJ projected great expectations, however the CEO expresses his concern of looking out for the best interest of its shareholders, and this is why they decided not go continue to persure this business venture. The tone of the letter reassures the shareholder that JNJ has their best interest inmind, they are concerned for their shareholders and want to be informative with them about what worked and what didn't work for them this past year. The letter trys to reinstate all the positive values that JNJ's products continue to give to its consumers. For example the iconic Tylenol has yet again reinvented itself with the Rapid Release-fast acting gel tablets, showing that they are constantly reintroducing new ideas and bringing new life to old iconic products. The PR messages are not just told once, twice, but three times. From reviewing the letter the key message of "continued success and growth" are repeated and backed up with firm hard examples of how new and old products have preformed this year and the letter is summed up with a glance into the future at what new and upcoming products JNJ will be releasing within the next fiscal year to keep the company growing and evolving.
• The last news finanical news release related to JNJ's company's earnings can easily be found on the website: http://www.investor.jnj.com/releaseDetail.cfm?ReleaseID=204087&year=2006
• To me, the news release was written in a technical language filled with lots of percentages, numbers and graphs and tables.

News Release:

J&J posts improved earnings
Blue chip open to 'small to mid-sized' acquisitions

By Val Brickates Kennedy, MarketWatch
Last Update: 1:03 PM ET Apr 18, 2006
BOSTON (MarketWatch) -- Health-care behemoth Johnson & Johnson reported modestly improved first-quarter earnings Tuesday, but revenue fell slightly shy of expectations due to increased generic competition for several of its prescription drugs.
For the quarter ended March 31, J&J had net income of $3.3 billion, or $1.10 a share, which included a $368 million after-tax gain associated with the termination of a merger agreement with rival medical-device maker Guidant Corp.,which instead will be acquired by Boston Scientific Corp. in a deal expected to close within days.

This compared with $2.8 billion, or 94 cents a share, earned in the first quarter of 2005.
Excluding various items, New Brunswick, N.J.-based J&J would have had adjusted earnings per share of 99 cents.
Revenue for the latest quarter climbed 1.2% to $12.99 billion, up from $12.83 billion in 2005.
A poll of analysts by Thomson First Call had estimated J&J would have earnings of 98 cents a share, on revenue of $13.218 billion.

Shares of J&J, part of the Dow Jones Industrial Average, traded modestly higher but failed to keep pace with the blue-chip barometer's sharp gains. See interactive charting.
J&J attributed its sluggish top-line performance to increasing generic competition affecting several of its drugs that have lost patent protection. That shortfall was partially offset by growth in its medical-devices division, which markets such popular products as coronary stents and orthopedic joint replacements.

"Our first-quarter results were as anticipated and we look forward to improving performance throughout the balance of the year," said William Weldon, J&J's chief executive, in a release.
"We are continuing to make significant investments in research and development in order to bring important new products to market, positioning us well for long-term growth," Weldon added.

On a call with analysts, J&J's vice-chairman and chief financial officer said that at this point, it was unlikely that the company would beat the current Wall Street analysts' mean estimates of earnings per share of 97 cents for the second-quarter and $3.68 for the year 2006. However, Robert Darretta did reiterate that the company's profit range was $3.65 to $3.72 a share for the year.

Sales from the company's core pharmaceutical division were $5.6 billion, down 2.2% from last year, including a negative currency impact of 1.8%.
Quarterly domestic drug sales dipped 2.2%, J&J said, largely due to generic competition. The company said that painkillers Duragesic and Ultracet, along with the antifungal medication Sporanox, were hardest hit by generics.

J&J said its strongest performers continued to be psychiatric drug Risperdal, rheumatoid arthritis medication Remicade, antiepileptic drug Topamax, and Concerta, prescribed for attention deficit hyperactivity disorder.
The picture was rosier in J&J's medical-devices division. Medical device sales, which included sales of its popular Cypher drug-coated coronary stents, came in at $5 billion, up 4.5% from last year.

On the call, Darretta said that J&J was "uncomfortable" with recent moves by Medicare regulators to possibly limit reimbursements for procedures to implant cardiac medical devices, adding it might have a chilling effect on technological advancement.

"We're uncomfortable with the changes that have been suggested," said Darretta. "We're hoping regulatory authorities will make appropriate adjustments to the proposal."
Also faring relatively well was the company's vast consumer-products business. Sales grew 3.3% to $2.4 billion, with adult skin-care lines Neutrogena and Aveeno the standout performers.
Regarding acquisitions, Darretta said that J&J will remain on the lookout for attractive deals, although they will likely be "small to mid-sized" in nature. Val Brickates Kennedy is a reporter for MarketWatch in Boston.

Social Responsibility

Why Do They Contribute?

"We are responsible to the communities in which we live and work and to the world community as well..." -- Our Credo

Johnson & Johnson, through its operating companies, is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 122,000 men and women in 57 countries and sell products throughout the world. Due to this, it only makes sense for Johnson & Johnson to give back to the community through a very wide ranging contributions to the environment, healthy & safety, HIV/AIDS, doctors and nurses, the list is always expanding. They have a responsibility to so many people becuase we use J&J products in our everyday lives.

Since the San Francisco earthquake of 1906 when Johnson & Johnson provided disaster relief for the first time, the Company’s commitment to corporate social responsibility has been integral part of its business. The creation of Our Credo in 1943 gave the Company a clear mandate for helping those in need, especially within the communities in which the Company operates worldwide.

Today, this continuing sense of responsibility to the global community is reflected in the Company’s signature contributions programs, ongoing monetary and product donations to innovative organizations around the world, and the volunteer efforts of the Company’s more than 116,000 employees and thousands of retirees.


Johnson & Johnson contributed $591.9 million in cash and products to philanthropic causes worldwide in 2005.

Johnson & Johnson is committed to improving the community through a variety of programs both in the United States and abroad. In cooperation with Johnson & Johnson, Medical Assistance Programs (MAP) International's Hurricane Katrina disaster relief efforts included making Medical Mission Packs available to physicians, drugs available to clinics and comfort supplies available to shelters. Additionally, a Web-based request system was established for products needs.